EUVIMEDEUVIMED entdecken
Multizentrische StudieKohortenstudieOpen Access

Transcranial Magnetic Stimulation Retreatment for Recurrent Depression: A Large Real‐World Multisite Cohort Study

Stanley Lyndon iD, Jason B Gibbons iD, Loreen Straub iD, Meekang Sung, Jacob C Jameson iD, David B Hathaway iD, Denise H Mulcahy, Cason Elliott, Rachel Wood iD, Matthew Ruble iD, Alejandro G Szmulewicz, Jie Yang und 4 weitere

Acta Psychiatrica Scandinavica · 2026-12 · 154 (6) · 408-417

DOI: 10.1111/acps.70130 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Acta Psychiatrica Scandinavica, online erschienen am 30.07.2026. Verfasst von Stanley Lyndon und 15 weiteren Autor:innen. Beteiligte Einrichtung: Harvard Medical School, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Transcranial Magnetic Stimulation, Major Depressive Disorder. Die Arbeit nennt 37 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NIMH NIH HHS, National Institute of Mental Health.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

When depressive symptoms return after an initial response to transcranial magnetic stimulation (TMS), evidence to guide use of a second acute course is strikingly limited. We aimed t o estimate how often and how quickly patients with recurrent major depressive disorder benefit from a second course of transcranial magnetic stimulation after they previously improved with TMS.

Methods

A retrospective cohort study across 20 outpatient centres included 259 patients who received ≥ 2 TMS courses between January 1, 2023 and October 1, 2025, and had clinically significant depressive symptoms at the start of course 2; 177 prior responders formed the primary cohort. Treatment used standard 10‐Hz left dorsolateral prefrontal cortex TMS. Response and remission were assessed using the PHQ‐9 and/or BDI‐II; response was defined as a ≥ 50% reduction and remission as PHQ‐9 ≤ 4 and/or BDI‐II ≤ 9. Symptom change from baseline to end of course 2 and time to first response by session were compared between courses.

Results

Among past responders, 146 of 177 patients (82.5%; 95% CI, 76.1%–87.8%) responded again during course 2 and 96 of 177 (54.2%; 95% CI, 46.6%–61.7%) achieved remission. PHQ‐9 scores decreased by a median of 65.0% ( p < 0.001), and BDI‐II scores decreased by a mean of 12.0 points (95% CI, −14.0 to −10.0; p < 0.001). Among responders, the first session meeting response criteria occurred earlier during retreatment than during the initial course on both PHQ‐9 (median session, 12 vs. 16; hazard ratio = 1.40, 95% CI, 1.14–1.72; p = 0.001) and BDI‐II (13.5 vs. 22.5; hazard ratio = 1.46, 95% CI, 1.07–2.00; p = 0.018).

Conclusions

Most patients who previously benefited from acute TMS improved again when symptoms recurred, and among responders, the first session meeting response criteria often occurred earlier during retreatment than during the initial course.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Transcranial Magnetic StimulationMajor Depressive DisorderHumansFemaleMaleMiddle AgedRetreatmentRetrospective StudiesAdultRecurrenceTreatment OutcomeCohort StudiesDorsolateral Prefrontal Cortex

Stichwörter der Autor:innen

major depressive disordermeasurement‐based carereal‐world cohortremissionresponse timingretreatmenttranscranial magnetic stimulation

Autor:innen und Institutionen

  • Harvard Medical School, Boston, Massachusetts, USA.
  • Department of Psychiatry, Mass General Brigham, Boston, Massachusetts, USA.
  • Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Harvard University, Boston, Massachusetts, USA.
  • Discovery Behavioral Health, Irvine, California, USA.
  • Department of Psychiatry, Cambridge Health Alliance, Boston, Massachusetts, USA.

ORCID-Profile: Stanley Lyndon, Jason B Gibbons, Loreen Straub, Jacob C Jameson, David B Hathaway, Rachel Wood, Matthew Ruble, Rajendra Aldis, Richard Wyss, Shan H Siddiqi

Förderung

  • NIMH NIH HHS
  • National Institute of Mental Health

Zitieren

APA

Lyndon, S., Gibbons, J. B., Straub, L., Sung, M., Jameson, J. C., Hathaway, D. B., Mulcahy, D. H., Elliott, C., Wood, R., Ruble, M., Szmulewicz, A. G., Yang, J., Aldis, R., Wyss, R., Wang, P. S., & Siddiqi, S. H. (2026). Transcranial Magnetic Stimulation Retreatment for Recurrent Depression: A Large Real‐World Multisite Cohort Study. Acta Psychiatrica Scandinavica, 154(6), 408-417. https://doi.org/10.1111/acps.70130

Vancouver

Lyndon S, Gibbons JB, Straub L, Sung M, Jameson JC, Hathaway DB, et al. Transcranial Magnetic Stimulation Retreatment for Recurrent Depression: A Large Real‐World Multisite Cohort Study. Acta Psychiatrica Scandinavica. 2026;154(6):408-417. doi:10.1111/acps.70130

BibTeX
@article{Lyndon2026,
  author = {Lyndon, Stanley and Gibbons, Jason B and Straub, Loreen and Sung, Meekang and Jameson, Jacob C and Hathaway, David B and Mulcahy, Denise H and Elliott, Cason and Wood, Rachel and Ruble, Matthew and Szmulewicz, Alejandro G and Yang, Jie and Aldis, Rajendra and Wyss, Richard and Wang, Philip S and Siddiqi, Shan H},
  title = {Transcranial Magnetic Stimulation Retreatment for Recurrent Depression: A Large Real‐World Multisite Cohort Study},
  journal = {Acta Psychiatrica Scandinavica},
  year = {2026},
  volume = {154},
  number = {6},
  pages = {408--417},
  doi = {10.1111/acps.70130}
}
Kostenlos starten →